NIPT for common aneuploidies (including sex chromosomes)
NIPT for common aneuploidies (including sex chromosomes) (plasma).
NIPT for fetal sexing (X-linked disorders)
NIPT for fetal sexing (X-linked disorders) (plasma).
Pharmacogenetics (panel testing)
Pharmacogenetic panel testing of markers for drug response and efficacy (Germline DNA).
Ovarian and Prostate Cancer (PARPi) [Tissue, Somatic]
BRCA1, BRCA2 and HRR testing for Ovarian and Prostate cancer in the context of PARP inhibitor prescription (FFPE). This EQA is sponsored.
NGS for germline SNVs and indels
EQA for quality of NGS for SNVs and indels <50bp (Germline DNA). For any NGS strategy (single gene, panel testing, whole exome sequencing or whole genome sequencing).
SANGER
EQA for quality of Sanger sequencing (PCR products and primers provided)